1.
Hematol Oncol Clin North Am
; 33(5): 887-901, 2019 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31466611
RESUMO
The approval of several new clotting factor concentrates and anticoagulation antidotes has resulted in increased complexity and cost of care. A multidisciplinary hemostatic stewardship program is essential to optimize utilization of these resources. This article summarizes the authors' approach to the stewardship of clotting factor concentrates and anticoagulation antidotes.